Category Language

Shortly after passage last year of the US healthcare reform act called for a regulatory pathway to bring follow-on biologic drugs, or biosimilars, to market with 12 years of data exclusivity for brand-name producers, the Obama administration has proposed to reduce that time to its original 7 years, according to sources. The move, contained in the 2012 budget proposal, is expected to allow lower priced generic versions of drugs to enter the market sooner, a benefit to consumers.

Watchdog organisation Corporate Europe Observatory (CEO) yesterday filed a complaint at the European General Court against the European Commission's denial of access to information on the EU-India bilateral trade talks.

The United States Patent and Trademark Office yesterday submitted a request to the US Congress for a budget increase in 2012 on expectations of a rise in patent and trademark applications and promises of reductions in application processing times.

A new study finds that publicly funded research has had a greater positive impact on public health than previously believed.

The non-profit ETC Group has released a report on global governance of nanoscale technologies that showed that thousands of patents are being granted on this still little understood area of science.

The United States Chamber of Commerce, the industry lobbying giant in Washington, has issued its 2011 intellectual property agenda. The list of suggested legislative changes to be made by the Obama administration and the US Congress aim at further increasing resources and support for IP enforcement, including legislation to block websites deemed to infringe on IP rights.